Parameter
| Biomarker | IL-10 | Full name | Interleukin 10 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | C153H238N40O47 | Molecular Weight | 3430.82 g/mol | Core Functional Dimensions | Prognosis, Disease Monitoring |
| Disease | Depression | Disease Subtypes | / | ||
| Organ | Brain | Test Sample / Technology Platform | Plasma (ELISA) | ||
| Pathobiological Mechanisms | Insufficient anti-inflammatory factors lead to neuroinflammatory imbalance, unable to antagonize the neurotoxic effects of IL-6/TNF-α. | ||||
| Clinical Availability Status | RResearch Stage | ||||
| Notes and Dynamics | IL-10 levels increase more than 2-fold in patients with effective antidepressant treatment, serving as a treatment response biomarker. | ||||